Screener
Trevi Therapeutics, Inc. TRVI Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.53B.
The source filing: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206390
FAQ
- What is Trevi Therapeutics, Inc.'s market capitalization?
- Trevi Therapeutics, Inc. (TRVI) reported market capitalization of $1.53B in Q1 2026.
- How has Trevi Therapeutics, Inc.'s market capitalization changed year-over-year?
- Trevi Therapeutics, Inc.'s market capitalization increased by 151.9% year-over-year, from $608.13M to $1.53B.
- What is the long-term trend for Trevi Therapeutics, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s market capitalization has grown at a 102.6% compound annual growth rate (CAGR), from $46.99M to $1.61B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Trevi Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude